Bladder Cancer, FISH

There are no preparation instructions.

The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.

Also known as: Bladder Cancer Fish

Bladder Cancer, Fish

*Important Information on Lab Test Processing Times: Ulta Lab Tests is committed to informing you about the processing times for your lab tests processed through a national lab. Please note that the estimated processing time for each test, indicated in business days, is based on data from the past 30 days across the 13 laboratories for each test. These estimates are intended to serve as a guide and are not guarantees. Factors such as laboratory workload, weather conditions, holidays, and the need for additional testing or maintenance can influence actual processing times. We aim to offer estimates to help you plan accordingly. Please understand that these times may vary, and processing times are not guaranteed. Thank you for choosing Ulta Lab Tests for your laboratory needs.

The Bladder Cancer, FISH test contains 1 test with 1 biomarker.

Description: The Bladder Cancer, Fluorescence In Situ Hybridization (FISH) test offered by Quest Diagnostics is a sophisticated diagnostic tool designed to detect chromosomal abnormalities associated with bladder cancer. This test is particularly useful for individuals who have symptoms suggestive of bladder cancer or those undergoing surveillance for bladder cancer.

Using a urine sample, the FISH test examines cells for specific genetic changes that are often present in bladder cancer cells. The test looks for abnormalities in chromosomes 3, 7, 9, and 17, as well as the loss of the 9p21 locus, which are common in bladder cancer cells. This approach enhances the detection of bladder cancer, especially in its early stages, and can be more sensitive than traditional cytology.

The Bladder Cancer, FISH test is recommended for individuals who have symptoms such as blood in the urine (hematuria), frequent urination, or painful urination. It is also a valuable tool for monitoring patients who have a history of bladder cancer, aiding in the early detection of recurrences.

Results from the FISH test should be interpreted by a healthcare professional in the context of the individual's clinical history and other diagnostic findings. Quest Diagnostics provides detailed results that can help guide further diagnostic testing, treatment decisions, and follow-up care for patients with bladder cancer or those at risk of developing it.

Customer Reviews